CRISPR Breakthrough at ChristianaCare Reverses Chemotherapy Resistance in Lung Cancer by Targeting NRF2 Gene
Scientists at ChristianaCare’s Gene Editing Institute have reached a pivotal milestone in oncology by demonstrating...
Knowledge and News for the Global Fight Against Cancer.
Scientists at ChristianaCare’s Gene Editing Institute have reached a pivotal milestone in oncology by demonstrating...
Neurodegenerative disorders, a group of debilitating conditions including Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease,...
Pancreatic cancer remains one of the most formidable challenges in modern oncology, characterized by its...
Luke Schoenbauer, a doctoral candidate in the physical therapy program at the University of Minnesota,...
CureSearch for Children’s Cancer, a leading national non-profit organization dedicated to ending childhood cancer by...
A groundbreaking preclinical study by Weill Cornell Medicine researchers has unveiled a revolutionary perspective on...
A groundbreaking study, slated for presentation at the prestigious American College of Cardiology’s Annual Scientific...
For decades, the genetic basis of cancer in domestic cats has remained largely a "black...
In a significant advancement for the field of oncology and immunotherapy, a team of researchers...
A groundbreaking study by Johns Hopkins Medicine scientists has illuminated a potential cellular mechanism that...